000			02032 a2200541 4500
005			20250513232022.0
264		0	_c20010329
008			200103s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.2001.19.2.584 _2doi
040			_aNLM _beng _cNLM
100	1		_aRudek, M A
245	0	0	_aPhase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cJan 2001
300			_a584-92 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xpharmacokinetics
650	0	4	_aEndothelial Growth Factors _xblood
650	0	4	_aEnzyme Inhibitors _xpharmacokinetics
650	0	4	_aFemale
650	0	4	_aFibroblast Growth Factor 2 _xblood
650	0	4	_aHumans
650	0	4	_aLymphokines _xblood
650	0	4	_aMale
650	0	4	_aMatrix Metalloproteinase 2 _xblood
650	0	4	_aMatrix Metalloproteinase 9 _xblood
650	0	4	_aMatrix Metalloproteinase Inhibitors
650	0	4	_aMatrix Metalloproteinases _xblood
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aStatistics, Nonparametric
650	0	4	_aTetracyclines _xpharmacokinetics
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
700	1		_aFigg, W D
700	1		_aDyer, V
700	1		_aDahut, W
700	1		_aTurner, M L
700	1		_aSteinberg, S M
700	1		_aLiewehr, D J
700	1		_aKohler, D R
700	1		_aPluda, J M
700	1		_aReed, E
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 19 _gno. 2 _gp. 584-92
856	4	0	_uhttps://doi.org/10.1200/JCO.2001.19.2.584 _zAvailable from publisher's website
999			_c11146800 _d11146800